Portal Instruments is developing and commercializing a highly innovative needle-free drug delivery platform technology to transform the administration of medicines and improve the patient experience for those with chronic disease who inject themselves. Portal’s needle-free delivery technology is derived from research at MIT and enables the administration of high viscosity biologic drugs with less discomfort and without the anxiety of handling needles. Using precise pressure technology, the injection is administered through the skin via a jet the size of a strand of hair, ensuring optimal comfort. Real time tracking and reporting sets a new standard for interactivity between the patient and care teams, monitoring adherence and potentially improving patient outcomes. Come join us on this exciting journey of redefining chronic patient care and comfort.
Location: United States, Massachusetts, Cambridge
Employees: 11-50
Phone: +1 617-500-4348
Total raised: $36M
Founded date: 2012
Investors 2
| Date | Name | Website |
| - | 5AM Ventur... | 5amventure... |
| - | Takeda Ven... | takeda.com |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 20.10.2015 | Series B | $25M | - |
| 16.10.2014 | Series A | $11M | - |
Mentions in press and media 9
| Date | Title | Description |
| 16.10.2025 | Portal and Regeneron Publish PRIME® Needle-Free Innovation Study, Informing Next-Generation Platform Development | Next Generation Platform: The PRIME NEXUS™ System consists of a reusable smart autoinjector unit and single-use disposable cassettes that are compatible with standard drug containers. Portal Instruments and Regeneron Publish PRIME® Needle-F... |
| 24.09.2025 | Portal Instruments and Gerresheimer Expand Partnership to Commercialize PRIME Nexus™ Reusable Autoinjector Platform | PRIME Nexus reusable, syringe- based, connected autoinjector platform with customizable cassette Combined development and manufacturing of PRIME Nexus™ provides comprehensive solution for pharma companies developing drug therapies to treat ... |
| 11.03.2024 | Needle-Free Injection System Market is growing at a CAGR of 17.91% from 2024 to 2030 by Exactitude Consultancy | Needle-Free Injection System market The Exactitude Consultancy Needle-Free Injection System Market Report – Size, Trends, and Forecast 2024-2030 The Needle-Free Injection System market is witnessing significant demand due to its painless an... |
| 28.06.2022 | Venture Leaders Medtech: 10 Swiss medtech startups showcase cutting-edge innovations in Boston | Venture Leaders Medtech: 10 Swiss medtech startups showcase cutting-edge innovations in Boston 28.06.2022 14:00, Tracy Woodley linkedIn facebook twitter instagram youtube --> The Venture Leaders— as members of the Swiss National Startup ... |
| 17.03.2017 | Meet The Finalists of SXSW Interactive Innovation Awards | Entrepreneurs, techies, and anyone with an appetite for innovation began to crowd the halls as the SXSW Interactive Innovation Awards announced the winners of its competition. Thirteen awards and six special honors were given to exceptional... |
| 25.10.2015 | PORTAL INSTRUMENTS CLOSES A $25 MILLION SERIES B FINANCING TO COMMERCIALIZE ITS TRANSFORMATIVE NEEDLE-FREE DRUG DELIVERY SYSTEM | - |
| 20.10.2015 | Portal Instruments Closes $25M Series B Financing | Portal Instruments, Inc., a Cambridge, MA-based clinical stage drug delivery device company, closed a $25m Series B financing round. The round was led by 5AM Ventures with participation from existing investors including Sanofi Sunrise. In c... |
| 16.10.2014 | Portal Instruments Completes $11M Series A Financing | Portal Instruments, Inc., a Cambridge, Massachusetts-based developer of innovative drug delivery systems, completed an $11m Series A financing. The round was led by Sanofi through its Sunrise initiative along with a Boston-based venture cap... |
| 15.10.2014 | Portal Instruments Completes $11M Series A | CAMBRIDGE, MA, Leader in the development of innovative drug delivery systems, announced today that it has completed a landmark $11 million Series A financing. >> Click here for more funding data on Portal Instruments >> To e... |